Prevention of Transmission of Hepatitis C Virus (HCV) From HCV-Viremic Organ Donor
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
This trial will be done in participants who undergo transplantation of heart, kidney or lung
at University of California, San Diego (UCSD) and receive a hepatitis C infected donor organ.
In this trial, the plan is to start hepatitis C treatment just before transplant surgery and
treat for a short one-week course to see if hepatitis C infection can be prevented in the
transplant recipient. The plan is to perform this trial in 10 participants and if successful,
the next step is to try to make it standard of care as prevention of infection is better than
treating hepatitis C after discharge from transplant surgery (which is usually a 12 week
standard treatment).